Clinical trial
Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis
NCT00432484 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00432484 |
|---|---|
| Title | Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis |
| Official title | Lingzhi (Ganoderma Lucidum) and Sen Miao San Supplementation in Rheumatoid Arthritis(RA): An Animal Model and A Phase I Study |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Lingzhi and Sen Miao San |
| Enrollment | 70 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Feb 7, 2007 |
| Last update posted | May 9, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: